Human glioblastoma‐associated microglia/monocytes express a distinct RNA profile compared to human control and murine samples

Glioblastoma (GBM) is the most aggressive brain tumor in adults. It is strongly infiltrated by microglia and peripheral monocytes that support tumor growth. In the present study we used RNA sequencing to compare the expression profile of CD11b+ human glioblastoma‐associated microglia/monocytes (hGAMs) to CD11b+ microglia isolated from non‐tumor samples. Hierarchical clustering and principal component analysis showed a clear separation of the two sample groups and we identified 334 significantly regulated genes in hGAMs. In comparison to human control microglia hGAMs upregulated genes associated with mitotic cell cycle, cell migration, cell adhesion, and extracellular matrix organization. We validated the expression of several genes associated with extracellular matrix organization in samples of human control microglia, hGAMs, and the hGAMs‐depleted fraction via qPCR. The comparison to murine GAMs (mGAMs) showed that both cell populations share a significant fraction of upregulated transcripts compared with their respective controls. These genes were mostly related to mitotic cell cycle. However, in contrast to murine cells, human GAMs did not upregulate genes associated to immune activation. Comparison of human and murine GAMs expression data to several data sets of in vitro‐activated human macrophages and murine microglia showed that, in contrast to mGAMs, hGAMs share a smaller overlap to these data sets in general and in particular to cells activated by proinflammatory stimulation with LPS + INFγ or TNFα. Our findings provide new insights into the biology of human glioblastoma‐associated microglia/monocytes and give detailed information about the validity of murine experimental models. GLIA 2016 GLIA 2016;64:1416–1436

[1]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[2]  Michael C. Ostrowski,et al.  E2f3 in tumor macrophages promotes lung metastasis , 2016, Oncogene.

[3]  M. Prados,et al.  Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. , 2016, Neuro-oncology.

[4]  Ginu A. Thomas,et al.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. , 2016, JCI insight.

[5]  Guangchuang Yu,et al.  ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. , 2016, Molecular bioSystems.

[6]  F. Ginhoux,et al.  New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.

[7]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[8]  B. Kamińska,et al.  Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma , 2015, Oncotarget.

[9]  Frauke Zipp,et al.  Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. , 2015, Immunity.

[10]  P. Vajkoczy,et al.  Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells , 2015, International Journal of Cancer.

[11]  M. Haniffa,et al.  Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species? , 2015, Front. Immunol..

[12]  O. Elemento,et al.  Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC , 2015, PloS one.

[13]  Zhihong Chen,et al.  Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis , 2015, Oncotarget.

[14]  Jill S Barnholtz-Sloan,et al.  Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.

[15]  T. Langmann,et al.  Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1 , 2015, PloS one.

[16]  F. Heppner,et al.  Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling. , 2015, Neuro-oncology.

[17]  Gary D Bader,et al.  Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity , 2015, Proceedings of the National Academy of Sciences.

[18]  H. Kettenmann,et al.  Glioma‐associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline , 2014, International journal of cancer.

[19]  Anna Da Fonseca,et al.  Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages , 2014, Journal of Neuroimmunology.

[20]  Peter Canoll,et al.  MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma , 2014, Proceedings of the National Academy of Sciences.

[21]  G. Fuller,et al.  Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. , 2014, Journal of the National Cancer Institute.

[22]  C. Dello Russo,et al.  The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype , 2014, Journal of Neuroinflammation.

[23]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[24]  Stein Aerts,et al.  iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections , 2014, PLoS Comput. Biol..

[25]  S. Sebens,et al.  Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. , 2014, Oncology reports.

[26]  D. Figarella-Branger,et al.  Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice , 2014, Oncogene.

[27]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[28]  Brian L. West,et al.  Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain , 2014, Neuron.

[29]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[30]  E. Latz,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.

[31]  A. Godwin,et al.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. , 2014, Critical reviews in oncology/hematology.

[32]  S. Weiss,et al.  Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells , 2013, Nature Neuroscience.

[33]  S. Gygi,et al.  Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia , 2013, Nature Neuroscience.

[34]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[35]  Ivan Cecconello,et al.  A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma , 2013, Journal of Gastroenterology.

[36]  H. Kettenmann,et al.  Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. , 2013, Neuro-oncology.

[37]  Toshiro K. Ohsumi,et al.  The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.

[38]  E. Mardis,et al.  F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma , 2013, PloS one.

[39]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[40]  Robert Gentleman,et al.  Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..

[41]  F. Finkernagel,et al.  Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse , 2013, International journal of cancer.

[42]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[43]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[44]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[45]  D. Koller,et al.  Conservation and divergence in the transcriptional programs of the human and mouse immune systems , 2013, Proceedings of the National Academy of Sciences.

[46]  L. Stein,et al.  Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome , 2012, Cancers.

[47]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[48]  R. Palmqvist,et al.  The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer , 2012, PloS one.

[49]  M. Graeber,et al.  The molecular profile of microglia under the influence of glioma. , 2012, Neuro-oncology.

[50]  Peng Zhang,et al.  Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway , 2012, The Journal of Immunology.

[51]  J. Segall,et al.  Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling , 2012, Molecular medicine.

[52]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[53]  D. Raj,et al.  An optimized protocol for the acute isolation of human microglia from autopsy brain samples , 2012, Glia.

[54]  B. Kamińska,et al.  Characteristics of the Alternative Phenotype of Microglia/Macrophages and its Modulation in Experimental Gliomas , 2011, PloS one.

[55]  Helmut Kettenmann,et al.  The brain tumor microenvironment , 2011, Glia.

[56]  H. Kettenmann,et al.  Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression , 2011, Brain, Behavior, and Immunity.

[57]  C. Brennan,et al.  Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations , 2009, PloS one.

[58]  T. Fennell,et al.  Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts , 2009, Genome Biology.

[59]  F. Heppner,et al.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.

[60]  M. Colombo,et al.  Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. , 2008, Cancer research.

[61]  Fabian Kiessling,et al.  Flt-1 signaling in macrophages promotes glioma growth in vivo. , 2008, Cancer research.

[62]  L. Sibley,et al.  Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. , 2008, Immunity.

[63]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[64]  R. Ádány,et al.  Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.

[65]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.

[66]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[67]  David J. Yang,et al.  Innate immune functions of microglia isolated from human glioma patients , 2006, Journal of Translational Medicine.

[68]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[69]  Behnam Badie,et al.  Microglia function in brain tumors , 2005, Journal of neuroscience research.

[70]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[71]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[72]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[73]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[74]  E. Oldfield,et al.  Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. , 1991, Journal of neurosurgery.

[75]  D. Rall,et al.  Studies on the chemotherapy of experimental brain tumors: development of an experimental model. , 1970, Cancer research.

[76]  A. Seligman,et al.  Studies in Carcinogenesis: VIII. Experimental Production of Brain Tumors in Mice with Methylcholanthrene , 1939 .

[77]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[78]  A. Ernst,et al.  Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. , 2012, Neuro-oncology.

[79]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[80]  K. Stocka,et al.  Gliomas induce and exploit microglial MT 1-MMP expression for tumor expansion , 2009 .

[81]  M. Kanehisa,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..